The Impact of Age, Sex, and Race on the Association of Risk Factors and Mortality in COVID-19 Patients

Solomon Sadie,Lighter Jennifer,Sheikh Rahayma,Hochman Sarah,Stachel Anna,Phillips Michael

doi:10.23937/2474-3658/1510215

Abstract

Retrospective analysis of adult patients with laboratory-confirmed Covid-19 from March 3rd - May 31<sup>st</sup> 2020 at NYU Langone Health. Patients selected had visited emergency departments, outpatient testing clinics, or were discharged from an inpatient location as of May 31<sup>st</sup> 2020. We assessed the moderating effects of patient demographics on the relationship between comorbidities and mortality.

Highlights

The emergence of coronavirus disease 2019 (Covid-19), caused by the SARS-CoV-2 virus, has triggered an ongoing global pandemic [1]
While generally at lower risk, patients with Covid-19 who were female, younger, white or black were at higher risk of mortality with certain comorbidities, compared to their appropriate control counterpart
In light of the sustained high number of Covid-19 cases and deaths throughout the United States [9], that we identify subsets of the population at high risk for Covid-19 mortality

Summary

Introduction

The emergence of coronavirus disease 2019 (Covid-19), caused by the SARS-CoV-2 virus, has triggered an ongoing global pandemic [1]. As of March 25th 2021 there have been over 124 million reported cases worldwide and over 2.7 million reported deaths. In the United States, there over 30 million confirmed cases with over 540,000 deaths [2]. In the spring of 2020 New York City was hit hard, as infection occurred on a population-wide scale prior to when testing became readily available. Previous studies have established risk factors among hospitalized patients, Citation: Solomon S, Hochman S, Sheikh R, Lighter J, Phillips M, et al (2021) The Impact of Age, Sex, and Race on the Association of Risk Factors and Mortality in COVID-19 Patients. Several comorbidities and demographic factors are associated with mortality in Covid-19 patients. Limited analysis exists of interactions between comorbidities and demographics for Covid-19 outcomes

Objectives

Methods

Results

Conclusion